University of Florida/Jacksonville

Jacksonville, Florida 32224

20 studies enrolling now · 86 studies all time

What they study most

AV Block, Acute Coronary Syndrome, Acute Pain, Acute Stroke, Alpha-1 Antitrypsin Deficiency, Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Atrial Fibrillation, Bacteremia, Bacteremia Due to Staphylococcus Aureus, Bacteremia Staph, Biliary Stricture

Studies at this site

• Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer — Recruiting now
• Study Evaluating Safety, Tolerability, and Metabolism of Niraparib — Recruiting now
• A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer — Recruiting now
• SELUTION 4 De Novo Small Vessel IDE Trial — Recruiting now
• Faricimab + PRP vs. Vitrectomy + Endolaser for Treatment of PDR — Recruiting now
• Multisite Inventory of Neonatal-Perinatal Interventions (MINI) Minimum Dataset — Recruiting now
• The Bridging Antiplatelet Therapy With Cangrelor 2 Study — Recruiting now
• RESTORE: REducing Future fractureS and Improving ouTcOmes of fRagility fracturE — Recruiting now
• A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy — Recruiting now
• Treatment of Acute Ischemic Stroke (ReMEDy2 Trial) — Recruiting now
• A Study to Evaluate the Clinical Outcomes of Efgartigimod PH20 SC in Adults With New-onset Generalized Myasthenia Gravis (gMG) — Recruiting now
• Effects of Low-dose Ticagrelor vs. Clopidogrel in Stable Patients Undergoing Elective Percutaneous Coronary Intervention — Recruiting now
• Switching From Dual Antiplatelet Therapy to Monotherapy With Potent P2Y12 Inhibitors — Recruiting now
• American Lung Association (ALA) Lung Health Cohort — Recruiting now
• The Impact of MeMed BV® on Management of Patients With Suspected Lower Respiratory Tract Infections (LRTI) in the Emergency Department (ED) and Urgent Care Center (UCC) ("JUPITER" TRIAL) — Recruiting now
• A Precision Medicine Approach to Identify Patients Undergoing Elective PCI at Risk of Peri-PCI Myocardial Infarction — Recruiting now
• Left vs Left Randomized Clinical Trial — Recruiting now
• MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles — Recruiting now
• InfasurfAero™ Versus Sham Treatment in Preterm Newborns With RDS — Recruiting now
• myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home — Recruiting now
• Home OCT-Guided Treatment Versus Treat and Extend for the Management of Neovascular AMD — Running, not enrolling
• CYP2D6 Genotype-guided Management of Opioid Analgesics in Patients Undergoing Elective Ventral Hernia Repairs — Running, not enrolling
• Fenofibrate for Prevention of DR Worsening — Running, not enrolling
• Florida Pancreas Collaborative Next Generation Biobank — Running, not enrolling
• A Study of mRNA-1647 Cytomegalovirus Vaccine in Healthy Participants 9 to 15 Years of Age and Participants 16 to 25 Years of Age — Completed
• Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD — Running, not enrolling
• CREST-2 Long-term Observational Extension Study — Running, not enrolling
• Long-term Safety and Tolerability of BHV-7000 — Enrolling by invitation
• Pivotal-Safety and Therapeutic Measures of tDCS in Patients With Refractory Focal Epilepsy — Completed
• A Depression and Opioid Pragmatic Trial in Pharmacogenetics (DCRI Coordinating Center) — Completed
• Genetic Testing to Understand and Address Renal Disease Disparities Across the United States — Completed
• A Study to Determine if BHV-7000 is Effective and Safe in Adults With Idiopathic Generalized Epilepsy With Generalized Tonic-clonic Seizures — Stopped early
• Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects With S. Aureus Bacteremia — Completed
• Assessment of Wound Closure Comparing Synthetic Hybrid-Scale Fiber Matrix With Standard of Care in Treating Diabetic Foot Ulcers (DFU) and With Living Cellular Skin Substitute in Treating Venous Leg Ulcers (VLU) — Stopped early
• Reparixin add-on Therapy to Standard Care to Limit Progression in Pts With COVID19 & Other Community Acquired Pneumonia — Stopped early
• Evaluation of Tonabersat for DME — Running, not enrolling
• A Study to Evaluate the Safety and Immunogenicity of the mRNA COVID-19 Vaccines in Healthy Children Between 6 Months to Less Than 6 Years of Age — Completed
• Does a Virtual Coach Offer a Better Solution for Weight Reduction in Ventral Hernia Patients With Obesity? — Completed
• A Study of Olezarsen Administered Subcutaneously to Participants With Severe Hypertriglyceridemia — Completed
• A Depression and Opioid Pragmatic Trial in Pharmacogenetics (Depression Trial) — Completed
• Genetic Testing to Understand and Address Renal Disease Disparities Across the United States Pharmacogenetic Substudy — Completed
• A Study to Evaluate Safety and Effectiveness of mRNA-1273 COVID-19 Vaccine in Healthy Children Between 6 Months of Age and Less Than 12 Years of Age — Completed
• A Depression and Opioid Pragmatic Trial in Pharmacogenetics (Chronic Pain Trial) — Completed
• Steroids and Surfactant in Extremely Low Gestation Age Infants Dose Escalation Trial — Stopped early
• A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke — Stopped early
• A Study to Evaluate the Efficacy and Safety of Reldesemtiv in Patients With Amyotrophic Lateral Sclerosis (ALS) — Stopped early
• Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following Large Hemispheric Infarction — Stopped early
• Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals — Completed
• Determination of the Prevalence and Severity of Expiratory Flow Limitation in Chronic Obstructive Pulmonary Disease Patients — Stopped early
• A Study to Evaluate XEN1101 as Adjunctive Therapy in Focal Epilepsy — Running, not enrolling